Advanced cardiac life support controversy: Where do antiarrhythmic agents fit in?

Pharmacotherapy

Volumn 17, Issue 2 SUPPL., 1997, Pages

  Chow, Moses S S ^a,b  

^a UNIVERSITY OF CONNECTICUT   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; AMIODARONE; ANTIARRHYTHMIC AGENT; BRETYLIUM TOSYLATE; LIDOCAINE; MAGNESIUM SULFATE; PLACEBO; PROCAINAMIDE;

BRADYCARDIA; CARDIOVERSION; CLINICAL PROTOCOL; CLINICAL TRIAL; CONFERENCE PAPER; DEFIBRILLATION; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; HYPOTENSION; INTRAVENOUS DRUG ADMINISTRATION; MEDICAL SOCIETY; NONHUMAN; RESPIRATION DEPRESSION; RESUSCITATION; SEIZURE; SUDDEN DEATH; VERTIGO;

AMIODARONE; ANIMALS; ANTI-ARRHYTHMIA AGENTS; BRETYLIUM COMPOUNDS; HUMANS; HYPOTENSION; INTENSIVE CARE; LIDOCAINE; TACHYCARDIA, VENTRICULAR; VENTRICULAR FIBRILLATION;

EID: 0030901468     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (36)

1. Yusuf S, Venkatesh G, Teo KK. Critical review of the approaches to the prevention of sudden death. Am J Cardiol 1993;72(16):51F-8.
2. Myerburg RJ, Conde CA, Sung RJ, et al. Clinical, electrophysiologic and hemodynamic profile of patients resuscitated from prehospital cardiac arrest. Am J Med 1980;68(4):568-76.
3. Cummins RO, ed. Textbook of advanced cardiac life support. Dallas, TX: American Heart Association, 1994.
4. Spear JF, Moore EN, Gersetenblith G. Effect of lidocaine on the ventricular fibrillation threshold in the dog during acute ischemia and premature ventricular contractions. Circulation 1972;46(1):65-73.
5. Kramer B, Gulker H, Meesmann W. The effects of lidocaine on the ventricular fibrillation threshold and primary ventricular fibrillation following acute experimental coronary occlusion. Basic Res Cardiol 1981;76(1):29-43.
6. de Langen CD, Balke CW, Spear JF, Levine JH, Moore EN. Interaction of metoprolol and lidocaine on the ventricular fibrillation threshold in the anesthetized dog. J Cardiovasc Pharmacol 1988;12:683-8.
7. Chow MS, Kluger J, DiPersio DM, Lawrence R, Fieldman A. Antifibrillatory effects of lidocaine and bretylium immediately postcardiopulmonary resuscitation. Am Heart J 1985; 110(5):938-43.
8. Hanyok JJ, Chow MS, Kluger J, Fieldman A. Antifibrillatory effects of high dose bretylium and a lidocaine-bretylium combination during cardiopulmonary resuscitation. Crit Care Med 1988;16(7):691-4.
9. Tacker WA, Niebauer MJ, Babbs CF, et al. The effect of newer antiarrhythmic drugs on defibrillation threshold. Crit Care Med 1980;8(3):177.
10. Euler DE, Scanlon PJ. Mechanism of the effect of bretylium on the ventricular fibrillation threshold in dogs. Am J Cardiol 1985;55(11):1396-401.
11. Kowey PR, Friehling TD, O'Connor KM, Wetstein L, Kelliher GJ. The effect of bretylium and clofilium on dispersion of refractoriness and vulnerability to ventricular fibrillation in the feline heart. Am Heart J 1985;110(2):363-70.
12. Bacaner M. Bretylium tosylate for suppression of induced ventricular fibrillation. Am J Cardiol 1966;17(4):528-34.
13. Holland K, Patterson E, Lucchesi BR. Prevention of ventricular fibrillation by bretylium in a conscious canine model of sudden coronary deaths. Am Heart J 19483;105(5):711-17.
14. Koo CC, Allen JD, Pantridge JF. Lack of effect of bretylium tosylate on electrical ventricular defibrillation in a controlled study. Cardiovasc Res 1984;18:762-7.
15. Yoon MS, Han J, Goel BG, Creamer P. Effect of procainamide on fibrillation threshold of normal and ischemic ventricles. Am J Cardiol 1974;33(2):238-42.
16. Nowak RM, Bodnar TJ, Dronen S, et al. Bretylium tosylate as initial treatment for cardiopulmonary arrest: randomized comparison with placebo. Ann Emerg Med 1981;10(8):404-7.
17. Olson DW, Thompson BM, Darin JC, Milbrath MH. A randomized comparison study of bretylium tosylate and lidocaine in resuscitation of patients from out-of-hospital ventricular fibrillation in a paramedic system. Ann Emerg Med 1984;13(9 pt 2):807-10.
18. Haynes RE, Chinn TL, Copass MK, Cobb LA. Comparison of bretylium tosylate and lidocaine in management of out of hospital ventricular fibrillation: a randomized clinical trial. Am J Cardiol 1981;49(2):353-6.
19. Block PJ, Winkle RA. Hemodynamic effects of antiarrhythmic drugs. Am J Cardiol 1983;52(6):14C-23.
20. Babbs CF, Yim GK, Whistler SJ, Tacker WA, Geddes LA. Elevation of ventricular defibrillation threshold in dogs by antiarrhythmic drugs. Am Heart J 1979;98(3):345-50.
21. Tacker WA, Niebauer MJ, Babbs CF, et al. The effect of newer antiarrhythmic drugs on defibrillation threshold. Crit Care Med 1980;8(3):177.
22. Kerber RE, Pandian NG, Jensen SR, et al. Effect of lidocaine and bretylium on energy requirements for transthoracic defibrillation: experimental studies. J Am Coll Cardiol 1986;7(2):397-405.
23. Chow MS, Kluger J, DiPersio DM, Lawrence R, Fieldman A. The effect of lidocaine and bretylium on the defibrillation threshold during cardiac arrest and cardiopulmonary resuscitation. Proc Soc Exp Biol Med 1986;182(1):63-7.
24. Bauernfeind RA, Hoff JV, Swiryn S, et al. Electrophysiologic testing of bretylium tosylate in sustained ventricular tachycardia. Am Heart J 1983;105(6):973-80.
25. Kowey PR, Levine JH, Herre JM, et al. Randomized, double-blind comparison of intravenous amiodarone and bretylium in the treatment of patients with recurrent, hemodynamically destabilizing ventricular tachycardia or fibrillation. The intravenous amiodarone multicenter investigators' group. Circulation 1995;92(11):3255-63.
26. Koo CC, Allen JD, Pantridge JF. Lack of effect of bretylium tosylate on electrical ventricular defibrillation in a controlled study. Cardiovasc Res 1984;18:762-7.
27. Chow MS, Ronfeld RA, Ruffett D, Fieldman A. Lidocaine pharmacokinetics during cardiac arrest and external cardiopulmonary resuscitation. Am Heart J 1981;102(4): 799-801.
28. Chow MS, Ronfeld RA, Hamilton RA, Helmink R, Fieldman A. Effect of external cardiopulmonary resuscitation on lidocaine pharmacokinetics in dogs. J Pharmacol Exp Ther 1983;224(3):531-7.
29. Arredondo MT, Guilen SG, Quinteiro RA. Effect of amiodarone on ventricular fibrillation and defibrillation thresholds in the canine heart under normal and ischemic conditions. Eur J Pharmacol 1986;125(1):23-8.
30. Gonzalez MD, Grin JJ, Venturini ED. Disparate effects of acute and chronic amiodarone on ventricular fibrillation threshold in dogs. J Am Coll Cardiol 1989;13(suppl 2):249A.
31. Zhou L, Chow MSS, Chen BP, Fan C, Kluger J. Electrophysiologic and antifibrillatory effects of amiodarone and desethylamiodarone [abstr]. J Am Coll Cardiol In press.
32. Fain ES, Lee JT, Winkle RA. Effect of acute intravenous and chronic oral amiodarone on defibrillation energy requirements. Am Heart J 1987;114(1 pt 1):8-18.
33. Zhou L, Chow MSS, Chen BP, Fan C, Kluger J. Acute effect of amiodarone and desethylamiodarone on defibrillation threshold [abstr]. J Am Coll Cardiol In press.
34. Frame LH. The effect of chronic oral and acute intravenous amiodarone administration on ventricular defibrillation threshold using implanted electrodes in dogs. Pacing Clin Electrophysiol 1989;12(2):339-46.
35. Williams ML, Woelfel A, Cascio WE, et al. Intravenous amiodarone during prolonged resuscitation from cardiac arrest. Ann Intern Med 1989;110(10):839-42.
36. Kentsch M, Berkel H, Bleifeld W. Intravenose amiodarone - applikation bei therapierefraktarem kammerflimmern. Intensivmedizin 1988;25:70-4.